State Street’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-147,789
| Closed | -$25.4K | – | 4874 |
|
|
2022
Q4 | $25.4K | Hold |
147,789
| – | – | ﹤0.01% | 4693 |
|
|
2022
Q3 | $64K | Hold |
147,789
| – | – | ﹤0.01% | 4604 |
|
|
2022
Q2 | $126K | Sell |
147,789
-846,338
| -85% | -$722K | ﹤0.01% | 4414 |
|
|
2022
Q1 | $5.48M | Sell |
994,127
-1,176,410
| -54% | -$6.48M | ﹤0.01% | 3134 |
|
|
2021
Q4 | $21M | Sell |
2,170,537
-186,848
| -8% | -$1.81M | ﹤0.01% | 2446 |
|
|
2021
Q3 | $42.2M | Sell |
2,357,385
-82,910
| -3% | -$1.48M | ﹤0.01% | 1933 |
|
|
2021
Q2 | $59.6M | Buy |
2,440,295
+1,798,409
| +280% | +$43.9M | ﹤0.01% | 1713 |
|
|
2021
Q1 | $17M | Sell |
641,886
-24,854
| -4% | -$659K | ﹤0.01% | 2468 |
|
|
2020
Q4 | $5.06M | Sell |
666,740
-7,721
| -1% | -$58.6K | ﹤0.01% | 2952 |
|
|
2020
Q3 | $3.38M | Sell |
674,461
-7,563
| -1% | -$37.9K | ﹤0.01% | 2979 |
|
|
2020
Q2 | $4.08M | Buy |
682,024
+25,469
| +4% | +$152K | ﹤0.01% | 2857 |
|
|
2020
Q1 | $2.92M | Sell |
656,555
-6,723
| -1% | -$29.9K | ﹤0.01% | 2884 |
|
|
2019
Q4 | $6.3M | Buy |
663,278
+38,060
| +6% | +$362K | ﹤0.01% | 2742 |
|
|
2019
Q3 | $4.91M | Buy |
625,218
+17,801
| +3% | +$140K | ﹤0.01% | 2798 |
|
|
2019
Q2 | $9.56M | Buy |
607,417
+95,959
| +19% | +$1.51M | ﹤0.01% | 2537 |
|
|
2019
Q1 | $9.26M | Buy |
511,458
+326,913
| +177% | +$5.92M | ﹤0.01% | 2507 |
|
|
2018
Q4 | $2.97M | Buy |
184,545
+28,875
| +19% | +$464K | ﹤0.01% | 2957 |
|
|
2018
Q3 | $3.74M | Buy |
+155,670
| New | +$3.74M | ﹤0.01% | 2995 |
|